Boothbay Fund Management, LLC Bristol Myers Squibb CO Call Options Transaction History

Boothbay Fund Management, LLC

  • $3.6 Billion
  • Q3 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$0.13 - $76.84 $533 - $315,044
4,100 Added 136.67%
7,100 $505,000
Q2 2022

Aug 15, 2022
SELL
$72.62 - $79.98 $508,340 - $559,860
-7,000 Reduced 70.0%
3,000 $231,000
Q1 2022

May 16, 2022
SELL
$61.48 - $73.72 $399,620 - $479,180
-6,500 Reduced 39.39%
10,000 $730,000
Q4 2021

Feb 14, 2022
BUY
$53.63 - $62.52 $884,895 - $1.03 Million
16,500 New
16,500 $1.03 Million

Others Institutions Holding BMY

# of Institutions
2,536
Shares Held
1.47B
Call Options Held
31.6M
Put Options Held
35M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Boothbay Fund Management, LLC Portfolio

Follow Boothbay Fund Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boothbay Fund Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email